In this video, Paul M. Ridker, MD, MPH, discusses his team's recent study, which found that vascular inflammation levels in patients on statin therapy are better predictors of future cardiovascular events...
Early adulthood hypertension or increased blood pressure is associated with negative brain changes later in life including lower regional brain volumes and worse white matter integrity, factors that are...
In this episode, Seth Martin, MD, speaks with Francoise Marvel, MD, about innovative approaches to implementing prevention guidelines, including the future of digital health and cardiovascular care.
In this commentary, Michael J. Bloch, MD, writes about the epidemiological link between influenza infection and cardiovascular events and the potential benefits of influenza vaccination on cardiovascular...
In this commentary, Michael J. Bloch, MD writes about controversies in the effect of dietary cholesterol and egg consumption on cardiovascular events and mortality.
In this article, James Matera, DO, writes about a newer agent, finarenone, which is a nonsteroidal, selective mineralocorticoid receptor antagonist that can treat chronic kidney disease.
He talks about the prevalence of sudden cardiac arrest among younger athletes, how to risk stratify this population, and the controversy around using electrocardiogram imaging in standard care.
Andres Pineda Maldonado, MD, from the University of Florida, Jacksonville, answers our questions about new therapies for mitral valve disease, the different recommendations for men vs women, and more.
Peter H. Jones, MD, discussed identifying high-risk patients and targeting specific lipid therapy to reduce risk of future cardiovascular disease events.
The Consumer Technology Association and Heart Rhythm Society have released new guidance on the best practices for consumers who use wearable devices. Lead author Nassir F. Marrouche, MD, from Tulane...
